The President emphasized the responsibility of the appointees and reinforced the importance of the agencies for the country's development

Learn about the differences between CBD and THC, their therapeutic uses in various diseases, and understand the legal landscape of medical cannabis in Brazil, which is advancing with regulations that expand safe access for thousands of patients

The safety and efficacy of cannabis-based products depend on an integrated chain involving chemists, biomedicals, pharmacists, and doctors — professionals who ensure, at each stage, the quality, stability, and trust in patient treatment

Companies report delays in shipments clearance, while official data from Anvisa indicate reduced average deadlines and high approval rates

Discover what medical cannabis is, what it's for, and how this treatment has been advancing in Brazil, with proven benefits and safe medical guidance

New US rule restricts hemp derivatives and opens opportunity for South American countries to meet part of the Brazilian demand

End of the Farm Bill shutdown in the US exposes Brazil's vulnerability due to lack of cultivation and lack of productive autonomy to ensure self-sufficiency

American measure rendering full spectrum extracts unfeasible has a long transition period, but already positions Uruguay as a new strategic export alternative

Regulatory agency bans commercialization and advertising of items from the brands due to lack of sanitary authorization; understand the decision and the companies' positions

The largest strategic meeting on medical cannabis and hemp in Brazil takes place in São Paulo, bringing together researchers, entrepreneurs, and professionals who are shaping the country's green future

During the 4th Brazilian Medicinal Cannabis Congress, the president of Sindusfarma emphasized that only clear and responsible regulation can ensure quality, trust, and safe access to plant-derived products.

Cannabis-based product deliveries are reaching the most remote places in Brazil, revealing the strength of a growing market

Public consultation allows society to give opinions on the agency's priorities for the next two years; preliminary list does not include cannabis

Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products

In Deusa Cast, a lawyer explains how Customs and Criminal Law act in preventing risks in the importation of cannabis-based products, ensuring safety and agility for companies in the sector

Document developed by a group with 31 Brazilian academic and research institutions points out regulatory barriers and suggests an agile framework to strengthen the scientific and technological sector

Social Affairs Committee confirms Safatle, Cerqueira, and Cardoso's names, in a moment of important reforms at the agency

Social Affairs Committee to analyze four names for leadership positions in health agencies

Event in São Paulo brings together regulators and experts to discuss regulation, cultivation, and the market landscape of the sector

Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control